Matches in SemOpenAlex for { <https://semopenalex.org/work/W4241543174> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4241543174 endingPage "2370" @default.
- W4241543174 startingPage "2364" @default.
- W4241543174 abstract "<b>Background: </b> In the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study, atorvastatin 80 mg/day reduced the risk of stroke in patients with recent stroke or TIA. Post hoc analysis found this overall benefit included an increase in the numbers of treated patients having hemorrhagic stroke (n = 55 for active treatment vs n = 33 for placebo). <b>Methods: </b> We explored the relationships between hemorrhage risk and treatment, baseline patient characteristics, most recent blood pressure, and most recent low-density lipoprotein (LDL) cholesterol levels prior to the hemorrhage. <b>Results: </b> Of 4,731 patients, 67% had ischemic strokes, 31% TIAs, and 2% hemorrhagic strokes as entry events. In addition to atorvastatin treatment (HR 1.68, 95% CI 1.09 to 2.59, <i>p</i> = 0.02), Cox multivariable regression including baseline variables significant in univariable analyses showed that hemorrhagic stroke risk was higher in those having a hemorrhagic stroke as the entry event (HR 5.65, 95% CI 2.82 to 11.30, <i>p</i> < 0.001), in men (HR 1.79, 95% CI 1.13 to 2.84, <i>p</i> = 0.01), and with age (10y increments, HR 1.42, 95% CI 1.16 to 1.74, <i>p</i> = 0.001). There were no statistical interactions between these factors and treatment. Multivariable analyses also found that having Stage 2 (JNC-7) hypertension at the last study visit before a hemorrhagic stroke increased risk (HR 6.19, 95% CI 1.47 to 26.11, <i>p</i> = 0.01), but there was no effect of most recent LDL-cholesterol level in those treated with atorvastatin. <b>Conclusions: </b> Hemorrhagic stroke was more frequent in those treated with atorvastatin, in those with a hemorrhagic stroke as an entry event, in men, and increased with age. Those with Stage 2 hypertension at the last visit prior to the hemorrhagic stroke were also at increased risk. Treatment did not disproportionately affect the hemorrhagic stroke risk associated with these other factors. There were no relationships between hemorrhage risk and baseline low-density lipoprotein (LDL) cholesterol level or recent LDL cholesterol level in treated patients." @default.
- W4241543174 created "2022-05-12" @default.
- W4241543174 creator A5001628967 @default.
- W4241543174 creator A5019348308 @default.
- W4241543174 creator A5023091399 @default.
- W4241543174 creator A5028934169 @default.
- W4241543174 creator A5031808771 @default.
- W4241543174 creator A5034280171 @default.
- W4241543174 creator A5057843713 @default.
- W4241543174 creator A5072470914 @default.
- W4241543174 date "2007-12-12" @default.
- W4241543174 modified "2023-10-03" @default.
- W4241543174 title "Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study" @default.
- W4241543174 doi "https://doi.org/10.1212/01.wnl.0000296277.63350.77" @default.
- W4241543174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18077795" @default.
- W4241543174 hasPublicationYear "2007" @default.
- W4241543174 type Work @default.
- W4241543174 citedByCount "300" @default.
- W4241543174 countsByYear W42415431742012 @default.
- W4241543174 countsByYear W42415431742013 @default.
- W4241543174 countsByYear W42415431742014 @default.
- W4241543174 countsByYear W42415431742015 @default.
- W4241543174 countsByYear W42415431742016 @default.
- W4241543174 countsByYear W42415431742017 @default.
- W4241543174 countsByYear W42415431742018 @default.
- W4241543174 countsByYear W42415431742019 @default.
- W4241543174 countsByYear W42415431742020 @default.
- W4241543174 countsByYear W42415431742021 @default.
- W4241543174 countsByYear W42415431742022 @default.
- W4241543174 countsByYear W42415431742023 @default.
- W4241543174 crossrefType "journal-article" @default.
- W4241543174 hasAuthorship W4241543174A5001628967 @default.
- W4241543174 hasAuthorship W4241543174A5019348308 @default.
- W4241543174 hasAuthorship W4241543174A5023091399 @default.
- W4241543174 hasAuthorship W4241543174A5028934169 @default.
- W4241543174 hasAuthorship W4241543174A5031808771 @default.
- W4241543174 hasAuthorship W4241543174A5034280171 @default.
- W4241543174 hasAuthorship W4241543174A5057843713 @default.
- W4241543174 hasAuthorship W4241543174A5072470914 @default.
- W4241543174 hasConcept C126322002 @default.
- W4241543174 hasConcept C127413603 @default.
- W4241543174 hasConcept C142724271 @default.
- W4241543174 hasConcept C164705383 @default.
- W4241543174 hasConcept C204787440 @default.
- W4241543174 hasConcept C27081682 @default.
- W4241543174 hasConcept C2777094939 @default.
- W4241543174 hasConcept C2777482532 @default.
- W4241543174 hasConcept C2777736543 @default.
- W4241543174 hasConcept C2778163477 @default.
- W4241543174 hasConcept C2780645631 @default.
- W4241543174 hasConcept C50382708 @default.
- W4241543174 hasConcept C67761136 @default.
- W4241543174 hasConcept C71924100 @default.
- W4241543174 hasConcept C78519656 @default.
- W4241543174 hasConcept C84393581 @default.
- W4241543174 hasConcept C90924648 @default.
- W4241543174 hasConceptScore W4241543174C126322002 @default.
- W4241543174 hasConceptScore W4241543174C127413603 @default.
- W4241543174 hasConceptScore W4241543174C142724271 @default.
- W4241543174 hasConceptScore W4241543174C164705383 @default.
- W4241543174 hasConceptScore W4241543174C204787440 @default.
- W4241543174 hasConceptScore W4241543174C27081682 @default.
- W4241543174 hasConceptScore W4241543174C2777094939 @default.
- W4241543174 hasConceptScore W4241543174C2777482532 @default.
- W4241543174 hasConceptScore W4241543174C2777736543 @default.
- W4241543174 hasConceptScore W4241543174C2778163477 @default.
- W4241543174 hasConceptScore W4241543174C2780645631 @default.
- W4241543174 hasConceptScore W4241543174C50382708 @default.
- W4241543174 hasConceptScore W4241543174C67761136 @default.
- W4241543174 hasConceptScore W4241543174C71924100 @default.
- W4241543174 hasConceptScore W4241543174C78519656 @default.
- W4241543174 hasConceptScore W4241543174C84393581 @default.
- W4241543174 hasConceptScore W4241543174C90924648 @default.
- W4241543174 hasIssue "Issue 24, Part 2" @default.
- W4241543174 hasLocation W42415431741 @default.
- W4241543174 hasLocation W42415431742 @default.
- W4241543174 hasOpenAccess W4241543174 @default.
- W4241543174 hasPrimaryLocation W42415431741 @default.
- W4241543174 hasRelatedWork W1972104334 @default.
- W4241543174 hasRelatedWork W2023123197 @default.
- W4241543174 hasRelatedWork W2098447701 @default.
- W4241543174 hasRelatedWork W2136240081 @default.
- W4241543174 hasRelatedWork W2142635793 @default.
- W4241543174 hasRelatedWork W2309823989 @default.
- W4241543174 hasRelatedWork W2380319386 @default.
- W4241543174 hasRelatedWork W3130514735 @default.
- W4241543174 hasRelatedWork W3151283227 @default.
- W4241543174 hasRelatedWork W4241543174 @default.
- W4241543174 hasVolume "70" @default.
- W4241543174 isParatext "false" @default.
- W4241543174 isRetracted "false" @default.
- W4241543174 workType "article" @default.